Urology · Hendersonville, TN
NPI
1194841452
Since 2007
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
107 Glen Oak Blvd
Hendersonville, TN, 37075
Phone (615) 822-9336
Groups this clinician bills Medicare through
Medicare paid, 2024
$969K
11,682 services
Medicare patients, 2024
1,061
Average age 76
Drug cost, 2024
$12.5M
6,174 prescriptions
Company payments, 2025
$92K
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Morris was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,400 times for 12 patients. In total David S Morris billed 11,682 services in 117 codes, and Medicare paid $969K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,400 | 12 | $4.99 | $12K |
| J0897 Injection, denosumab, 1 mg | Office | 1,860 | 11 | $20.87 | $39K |
| 99214 Office E&M - Established | Office | 932 | 604 | $81.30 | $76K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 839 | 621 | $11.44 | $9,601 |
| 84153 Clinical Chemistry | Office | 606 | 356 | $17.92 | $11K |
| 81003 Clinical Chemistry | Office | 564 | 437 | $2.17 | $1,221 |
| 36415 Venipuncture Blood Collection | Office | 523 | 309 | $8.60 | $4,500 |
| 99213 Office E&M - Established | Office | 489 | 407 | $55.33 | $27K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 486 | 62 | $140.36 | $68K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 462 | 11 | $46.78 | $22K |
| 81001 Clinical Chemistry | Office | 460 | 332 | $3.09 | $1,419 |
| 84403 Clinical Chemistry | Office | 402 | 199 | $25.18 | $10K |
| 99204 Office E&M - New | Office | 121 | 121 | $102.61 | $12K |
| 96402 Chemotherapy Administration | Office | 96 | 69 | $22.80 | $2,189 |
| 87086 Bacterial Culture | Office | 60 | 48 | $7.80 | $468 |
By year: 2022 $463K for 16,070 services; 2023 $908K for 14,793 services; 2024 $969K for 11,682 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84153 Clinical Chemistry | 606 | 356 | $17.92 | $11K |
| 81003 Clinical Chemistry | 564 | 437 | $2.17 | $1,221 |
| 36415 Venipuncture Blood Collection | 523 | 309 | $8.60 | $4,500 |
| 81001 Clinical Chemistry | 460 | 332 | $3.09 | $1,419 |
| 84403 Clinical Chemistry | 402 | 199 | $25.18 | $10K |
| 87086 Bacterial Culture | 60 | 48 | $7.80 | $468 |
| 80053 Clinical Chemistry | 57 | 32 | $10.35 | $590 |
| 85025 Blood Count | 54 | 37 | $7.61 | $411 |
| 87077 Bacterial Culture | 32 | 27 | $7.71 | $247 |
| 87186 General Laboratory | 30 | 26 | $8.48 | $254 |
Medicare prescription drug claims, 2024
In 2024, the drug David S Morris prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,141 prescriptions and refills. In total David S Morris wrote 6,174 Medicare prescriptions that cost $12.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,141 | 3,116 | 362 | $17K |
| Finasteride Generic | 686 | 1,984 | 229 | $11K |
| Orgovyx Relugolix | 492 | 492 | 93 | $1.3M |
| Solifenacin Succinate Generic | 370 | 808 | 138 | $29K |
| Prednisone Generic | 325 | 355 | 60 | $1,135 |
| Xtandi Enzalutamide | 322 | 322 | 59 | $4.3M |
| Abiraterone Acetate Generic | 321 | 321 | 54 | $715K |
| Myrbetriq Mirabegron | 320 | 467 | 73 | $205K |
| Erleada Apalutamide | 311 | 317 | 51 | $4.4M |
| Oxybutynin Chloride Er Oxybutynin Chloride | 195 | 438 | 61 | $3,989 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 176 | 176 | 136 | $1,712 |
| Testosterone Cypionate Generic | 157 | 199 | 36 | $4,306 |
| Gemtesa Vibegron | 136 | 166 | 31 | $76K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 119 | 309 | 36 | $2,071 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 118 | 118 | 72 | $314 |
Brand drugs: 1,796 claims; generic drugs: 4,378 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Morris $92K ($92K in general payments such as food, travel and fees) from 39 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $26K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 33 | $26K |
| Janssen Biotech, Inc. JNJ | 30 | $15K |
| Astellas Pharma US Inc 4503.T | 14 | $9,331 |
| Pfizer Inc. PFE | 17 | $7,393 |
| Merck Sharp & Dohme LLC MRK | 9 | $5,600 |
| Tolmar, Inc. | 13 | $5,337 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $4,050 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $3,486 |
| Dendreon Pharmaceuticals LLC | 38 | $2,994 |
| AstraZeneca UK Limited AZN | 2 | $2,560 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.